These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22086914)

  • 1. Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.
    Wang Y; Pinto JR; Solis RS; Dweck D; Liang J; Diaz-Perez Z; Ge Y; Walker JW; Potter JD
    J Biol Chem; 2012 Jan; 287(3):2156-67. PubMed ID: 22086914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation.
    Cheng Y; Rao V; Tu AY; Lindert S; Wang D; Oxenford L; McCulloch AD; McCammon JA; Regnier M
    J Biol Chem; 2015 Nov; 290(46):27749-66. PubMed ID: 26391394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
    Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
    J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.
    Cheng Y; Lindert S; Oxenford L; Tu AY; McCulloch AD; Regnier M
    J Phys Chem B; 2016 Aug; 120(33):8238-53. PubMed ID: 27150586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The R21C Mutation in Cardiac Troponin I Imposes Differences in Contractile Force Generation between the Left and Right Ventricles of Knock-In Mice.
    Liang J; Kazmierczak K; Rojas AI; Wang Y; Szczesna-Cordary D
    Biomed Res Int; 2015; 2015():742536. PubMed ID: 25961037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
    Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling.
    Bardswell SC; Cuello F; Rowland AJ; Sadayappan S; Robbins J; Gautel M; Walker JW; Kentish JC; Avkiran M
    J Biol Chem; 2010 Feb; 285(8):5674-82. PubMed ID: 20018870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation.
    Kobayashi T; Dong WJ; Burkart EM; Cheung HC; Solaro RJ
    Biochemistry; 2004 May; 43(20):5996-6004. PubMed ID: 15147183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres.
    Dvornikov AV; Smolin N; Zhang M; Martin JL; Robia SL; de Tombe PP
    J Biol Chem; 2016 Oct; 291(41):21817-21828. PubMed ID: 27557662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.
    Nixon BR; Thawornkaiwong A; Jin J; Brundage EA; Little SC; Davis JP; Solaro RJ; Biesiadecki BJ
    J Biol Chem; 2012 Jun; 287(23):19136-47. PubMed ID: 22493448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the functional significance of the acidic region of the unique N-terminal extension of cardiac troponin I.
    Henze M; Patrick SE; Hinken A; Scruggs SB; Goldspink P; de Tombe PP; Kobayashi M; Ping P; Kobayashi T; Solaro RJ
    Biochim Biophys Acta; 2013 Apr; 1833(4):823-32. PubMed ID: 22940544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.
    Deng Y; Schmidtmann A; Kruse S; Filatov V; Heilmeyer LM; Jaquet K; Thieleczek R
    J Mol Cell Cardiol; 2003 Nov; 35(11):1365-74. PubMed ID: 14596793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of site-specific phosphorylation of protein kinase A sites Ser23 and Ser24 of cardiac troponin I in human cardiomyocytes.
    Wijnker PJ; Foster DB; Tsao AL; Frazier AH; dos Remedios CG; Murphy AM; Stienen GJ; van der Velden J
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H260-8. PubMed ID: 23144315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal phosphorylation of cardiac troponin-I reduces length-dependent calcium sensitivity of contraction in cardiac muscle.
    Rao VS; Korte FS; Razumova MV; Feest ER; Hsu H; Irving TC; Regnier M; Martyn DA
    J Physiol; 2013 Jan; 591(2):475-90. PubMed ID: 23129792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy.
    Barta J; Tóth A; Jaquet K; Redlich A; Edes I; Papp Z
    Mol Cell Biochem; 2003 Sep; 251(1-2):83-8. PubMed ID: 14575308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.
    Pi Y; Zhang D; Kemnitz KR; Wang H; Walker JW
    J Physiol; 2003 Nov; 552(Pt 3):845-57. PubMed ID: 12923217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monophosphorylation of cardiac troponin-I at Ser-23/24 is sufficient to regulate cardiac myofibrillar Ca
    Martin-Garrido A; Biesiadecki BJ; Salhi HE; Shaifta Y; Dos Remedios CG; Ayaz-Guner S; Cai W; Ge Y; Avkiran M; Kentish JC
    J Biol Chem; 2018 Jun; 293(22):8588-8599. PubMed ID: 29669813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function.
    Haworth RS; Cuello F; Herron TJ; Franzen G; Kentish JC; Gautel M; Avkiran M
    Circ Res; 2004 Nov; 95(11):1091-9. PubMed ID: 15514163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.